NuGen Announces Acquisition of 4MW Operational Solar Project in Tolland, Massachusetts

NuGen Capital Management is pleased to announce the recent acquisition of an operational 4MW SREC 1 solar project in Tolland, Massachusetts. This marks the largest purchase of a fully operational project by NuGen. The electricity generated by the project is sold to two local Municipalities. This latest addition brings NuGenʼs Massachusetts SREC 1 solar portfolio to over 17MW.

"As part of our ongoing strategy to purchase operational projects, we are pleased to add this 4MW asset to our Massachusetts SREC 1 portfolio. We are confident with net metering credits and SREC values which gives us a competitive advantage in terms of overall valuation and speed to close for developers and companies interested in selling operational assets," said David Milner, Chief Executive Officer at NuGen Capital.

NuGen is in the process of adding 15MW of generation to its portfolio that it expects to be operational in 2015. NuGen seeks additional solar and real estate financing opportunities in the USA and abroad.

About NuGen Capital

NuGen Capital Management owns, operates and develops renewable energy projects and invests in real estate conducive to energy generation. NuGen invests in grid connected and behind the meter utility and large scale solar projects. Real estate investments include large parcels of land and commercial properties where solar energy and battery storage are viable. Based in Rhode Island, NuGen seeks opportunities where renewable energy policies encourage job creation and energy sustainability. www.nugencapital.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.